Ladenburg Thalmann Starts Genetic Technologies (GENE) at Buy
GENE Hot Sheet
Rating Summary:1 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Ladenburg Thalmann initiates coverage on Genetic Technologies (NASDAQ: GENE) with a Buy. PT $7.50.
For an analyst ratings summary and ratings history on Genetic Technologies click here. For more ratings news on Genetic Technologies click here.
Shares of Genetic Technologies closed at $3.25 yesterday, with a 52 week range of $0.70-$10.75.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on Genetic Technologies click here. For more ratings news on Genetic Technologies click here.
Shares of Genetic Technologies closed at $3.25 yesterday, with a 52 week range of $0.70-$10.75.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: Capstone Starts Facebook (FB) at Hold as Premium Multiple Not Justified
- UBS Maintains a 'Neutral' on Patterson Companies (PDCO); Raising 'The Bar' and Estimates
- Pre-Open Movers 5/25: (BLOX) (FRO) (QSFT) Higher; (TLB) (ROSG) (DCTH) Lower (more...)
Create E-mail Alert Related Categories
New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
